Exp Clin Endocrinol Diabetes 1989; 93(2/03): 299-306
DOI: 10.1055/s-0029-1210872
Original

© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

The Effects of Glibenclamide and its Non-Sulfonylurea Analogue HB 699 on the Sodium Content of Rat Pancreatic Islets

L. Ali, N. Wesslén, B. Hellman
  • Department of Medical Cell Biology, University of Uppsala, Sweden
Further Information

Publication History

1988

Publication Date:
16 July 2009 (online)

Summary

Sodium contents were determined in rat pancreatic islets using integrating flame photometry. Whereas the sodium content decreased in the presence of glucose, it increased when 0.1—100 μmol/1 glibenclamide was added to a medium containing 3 mmol/1 glucose. The complexity of the glibenclamide action became evident with its reversal after removal of extracellular Ca2+ and the observation that the sulfonylurea counteracted the increase of sodium obtained after removal of K+. The effects of glibenclamide were mimicked by 1 mmol/1 of its non-sulfonylurea analogue HB 699 with the exception that the latter compound being without suppressive action on the sodium content in medium deprived of Ca2+- Also exposure to 1 mmol/1 sulfadiazine resulted in a Ca2+-dependent increase of sodium. The results suggest a role for sodium in amplifying the secretory response to the increased entry of Ca2+ obtained with the depolarisation of the β-cells with glibenclamide or HB 699.

    >